Non-lamellar lyotropic liquid crystalline nanoparticles enhance the antibacterial effects of rifampicin against Staphylococcus aureus

Journal of Colloid and Interface Science

Volumn 519, Issue , 2018, Pages 107-118

  Tran, Nhiem ^a   Hocquet, Marion ^b,c   Eon, Blandine ^b,c   Sangwan, Parveen ^b   Ratcliffe, Julian ^b   Hinton, Tracey M ^b   White, Jacinta ^b   Ozcelik, Berkay ^b   Reynolds, Nicholas P ^d   Muir, Benjamin W ^b  

^a RMIT UNIVERSITY   (Australia)

^b CSIRO   (Australia)

^c PSL RESEARCH UNIVERSITY   (France)

^d SWINBURNE UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

Antibacterial; Cubosome; Cytotoxicity; Lipid; MIC; Nanoparticles; Rifampicin

Indexed keywords

ANTIBIOTICS; ATOMIC FORCE MICROSCOPY; BACTERIA; BINDING ENERGY; BINS; CYTOTOXICITY; ENERGY TRANSFER; ENZYME INHIBITION; FLUORINE; HIGH RESOLUTION TRANSMISSION ELECTRON MICROSCOPY; LANTHANUM COMPOUNDS; LIPIDS; MEDICAL NANOTECHNOLOGY; PH; SULFUR COMPOUNDS; TRANSMISSION ELECTRON MICROSCOPY;

ANTI-BACTERIAL ACTIVITY; ANTIBACTERIAL; ANTIBIOTIC-RESISTANT BACTERIA; CUBOSOMES; FLUORESCENT MICROSCOPY; LYOTROPIC LIQUID CRYSTALLINE; MINIMUM INHIBITORY CONCENTRATION; RIFAMPICIN;

NANOPARTICLES;

1,2 DIOLEOYL 3 TRIMETHYLAMMONIOPROPANE; GLYCEROL OLEATE; NANOPARTICLE; RIFAMPICIN; ACYLGLYCEROL; ANTIINFECTIVE AGENT; DRUG CARRIER;

ANIMAL CELL; ANTIBACTERIAL ACTIVITY; ARTICLE; ATOMIC FORCE MICROSCOPY; BACTERIAL MEMBRANE; CELL VIABILITY; CHO CELL LINE; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; FLUORESCENCE MICROSCOPY; FLUORESCENCE RESONANCE ENERGY TRANSFER; HELA CELL LINE; HUMAN; HUMAN CELL; LIQUID CRYSTAL; MEMBRANE DAMAGE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STATIC ELECTRICITY; TRANSMISSION ELECTRON MICROSCOPY; ANIMAL; CELL SURVIVAL; CHEMISTRY; CRICETULUS; DRUG EFFECT; DRUG RELEASE; MICROBIAL SENSITIVITY TEST; PARTICLE SIZE; SURFACE PROPERTY;

ANIMALS; ANTI-BACTERIAL AGENTS; CELL SURVIVAL; CHO CELLS; CRICETULUS; DRUG CARRIERS; DRUG LIBERATION; GLYCERIDES; HELA CELLS; HUMANS; LIQUID CRYSTALS; MICROBIAL SENSITIVITY TESTS; NANOPARTICLES; PARTICLE SIZE; RIFAMPIN; STAPHYLOCOCCUS AUREUS; SURFACE PROPERTIES;

EID: 85042398536     PISSN: 00219797     EISSN: 10957103     Source Type: Journal    
DOI: 10.1016/j.jcis.2018.02.048     Document Type: Article

References (77)

1. Ventola, C.L., The antibiotic resistance crisis: part 1: causes and threats. Pharm. Therap., 40(4), 2015, 277.
2. Kuo, L.-C., Teng, L.-J., Yu, C.-J., Ho, S.-W., Hsueh, P.-R., Dissemination of a clone of unusual phenotype of pandrug-resistant Acinetobacter baumannii at a university hospital in Taiwan. J. Clin. Microbiol. 42:4 (2004), 1759–1763.
3. H.C. Maltezou, Metallo-β-lactamases in gram-negative bacteria: introducing the era of pan-resistance?, Int. J. Antimicrobial Agents 33(5) (2009) 405. e1-405. e7.
4. Fishbain, J., Peleg, A.Y., Treatment of Acinetobacter infections. Clin. Infect. Dis. 51:1 (2010), 79–84.
5. H.W. Boucher, Challenges in anti-infective development in the era of bad bugs, no drugs: a regulatory perspective using the example of bloodstream infection as an indication, Clin. Infect. Dis. 50 (Suppl. 1) (2010) S4–S9.
6. Molton, J.S., Tambyah, P.A., Ang, B.S., Ling, M.L., Fisher, D.A., The global spread of healthcare-associated multidrug-resistant bacteria: a perspective from Asia. Clin. Infect. Dis. 56:9 (2013), 1310–1318.
7. Falagas, M.E., Tansarli, G.S., Karageorgopoulos, D.E., Vardakas, K.Z., Deaths attributable to carbapenem-resistant Enterobacteriaceae infections. Emerg. Infect. Dis., 20(7), 2014, 1170.
8. Bush, K., Courvalin, P., Dantas, G., Davies, J., Eisenstein, B., Huovinen, P., Jacoby, G.A., Kishony, R., Kreiswirth, B.N., Kutter, E., Tackling antibiotic resistance. Nat. Rev. Microbiol., 9(12), 2011, 894.
9. Silver, L.L., Challenges of antibacterial discovery. Clin. Microbiol. Rev. 24:1 (2011), 71–109.
10. Huh, A.J., Kwon, Y.J., “Nanoantibiotics”: a new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era. J. Control. Release 156:2 (2011), 128–145.
11. Zhu, X., Radovic-Moreno, A.F., Wu, J., Langer, R., Shi, J., Nanomedicine in the management of microbial infection–overview and perspectives. Nano Today 9:4 (2014), 478–498.
12. Tran, N., Tran, P.A., Nanomaterial-based treatments for medical device-associated infections. ChemPhysChem 13:10 (2012), 2481–2494.
13. Azzopardi, E.A., Ferguson, E.L., Thomas, D.W., The enhanced permeability retention effect: a new paradigm for drug targeting in infection. J. Antimicrob. Chemother. 68:2 (2012), 257–274.
14. Duncan, R., The dawning era of polymer therapeutics. Nat. Rev. Drug Discovery, 2(5), 2003, 347.
15. Evans, D.J., Evans, D.G., Gorbach, S.L., Production of vascular permeability factor by enterotoxigenic Escherichia coli isolated from man. Infect. Immun. 8:5 (1973), 725–730.
16. Laverman, P., Boerman, O.C., Oyen, W.J., Dams, E.T.M., Storm, G., Corstens, F.H., Liposomes for scintigraphic detection of infection and inflammation. Adv. Drug Deliv. Rev. 37:1 (1999), 225–235.
17. P. Laverman, O.C. Boerman, W.J. Oyen, F.H. Corstens, G. Storm, In vivo applications of PEG liposomes: unexpected observations, Crit. Rev.™ Therap. Drug Carrier Syst., 18(6) (2001).
18. Laverman, P., Dams, E.T.M., Storm, G., Hafmans, T.G., Croes, H.J., Oyen, W.J., Corstens, F.H., Boerman, O.C., Microscopic localization of PEG-liposomes in a rat model of focal infection. J. Controll. Release 75:3 (2001), 347–355.
19. Wang, S., Singh, A.K., Senapati, D., Neely, A., Yu, H., Ray, P.C., Rapid colorimetric identification and targeted photothermal lysis of Salmonella bacteria by using bioconjugated oval-shaped gold nanoparticles. Chem.-A Euro. J. 16:19 (2010), 5600–5606.
20. Zhang, J., Chen, Y.P., Miller, K.P., Ganewatta, M.S., Bam, M., Yan, Y., Nagarkatti, M., Decho, A.W., Tang, C., Antimicrobial metallopolymers and their bioconjugates with conventional antibiotics against multidrug-resistant bacteria. J. Am. Chem. Soc. 136:13 (2014), 4873–4876.
21. Mei, L., Lu, Z., Zhang, W., Wu, Z., Zhang, X., Wang, Y., Luo, Y., Li, C., Jia, Y., Bioconjugated nanoparticles for attachment and penetration into pathogenic bacteria. Biomaterials 34:38 (2013), 10328–10337.
22. Liu, L., Xu, K., Wang, H., Tan, P.J., Fan, W., Venkatraman, S.S., Li, L., Yang, Y.-Y., Self-assembled cationic peptide nanoparticles as an efficient antimicrobial agent. Nat. Nanotechnol. 4:7 (2009), 457–463.
23. Fong, C., Le, T., Drummond, C.J., Lyotropic liquid crystal engineering–ordered nanostructured small molecule amphiphile self-assembly materials by design. Chem. Soc. Rev. 41:3 (2012), 1297–1322.
24. Seddon, J., Templer, R., Polymorphism of lipid-water systems. Handbook Biol. Phys. 1 (1995), 97–160.
25. Torchilin, V.P., Recent advances with liposomes as pharmaceutical carriers. Nat. Rev. Drug Discovery 4:2 (2005), 145–160.
26. Chang, H.-I., Yeh, M.-K., Clinical development of liposome-based drugs: formulation, characterization, and therapeutic efficacy. Int. J. Nanomed., 7(4), 2012.
27. Torchilin, V.P., Multifunctional nanocarriers. Adv. Drug Deliv. Rev. 64 (2012), 302–315.
28. Allen, T.M., Cullis, P.R., Liposomal drug delivery systems: from concept to clinical applications. Adv. Drug Deliv. Rev. 65:1 (2013), 36–48.
29. Borné, J., Nylander, T., Khan, A., Phase behavior and aggregate formation for the aqueous monoolein system mixed with sodium oleate and oleic acid. Langmuir 17:25 (2001), 7742–7751.
30. Yaghmur, A., Sartori, B., Rappolt, M., Self-assembled nanostructures of fully hydrated monoelaidin–elaidic acid and monoelaidin–oleic acid systems. Langmuir 28:26 (2012), 10105–10119.
31. Negrini, R., Mezzenga, R., pH-responsive lyotropic liquid crystals for controlled drug delivery. Langmuir 27:9 (2011), 5296–5303.
32. Dong, Y.-D., Larson, I., Hanley, T., Boyd, B.J., Bulk and dispersed aqueous phase behavior of phytantriol: effect of vitamin E acetate and F127 polymer on liquid crystal nanostructure. Langmuir 22:23 (2006), 9512–9518.
33. Tran, N., Mulet, X., Hawley, A.M., Hinton, T.M., Mudie, S.T., Muir, B.W., Giakoumatos, E.C., Waddington, L.J., Kirby, N.M., Drummond, C.J., Nanostructure and cytotoxicity of self-assembled monoolein-capric acid lyotropic liquid crystalline nanoparticles. RSC Adv. 5:34 (2015), 26785–26795.
34. Tran, N., Mulet, X., Hawley, A., Conn, C.E., Zhai, J., Waddington, L.J., Drummond, C.J., First direct observation of stable internally ordered janus nanoparticles created by lipid self-assembly. Nano Lett. 15:6 (2015), 4229–4233.
35. Zhai, J., Scoble, J.A., Li, N., Lovrecz, G., Waddington, L.J., Tran, N., Muir, B.W., Coia, G., Kirby, N., Drummond, C.J., Epidermal growth factor receptor-targeted lipid nanoparticles retain self-assembled nanostructures and provide high specificity. Nanoscale 7 (2015), 2905–2913.
36. Clogston, J., Caffrey, M., Controlling release from the lipidic cubic phase amino acids, peptides, proteins and nucleic acids. J. Controll. Release 107:1 (2005), 97–111.
37. Angelov, B., Angelova, A., Filippov, S.K., Drechsler, M., Štěpánek, P., Lesieur, S., Multicompartment lipid cubic nanoparticles with high protein upload: millisecond dynamics of formation. ACS Nano 8:5 (2014), 5216–5226.
38. Angelova, A., Angelov, B., Mutafchieva, R., Lesieur, S., Couvreur, P., Self-assembled multicompartment liquid crystalline lipid carriers for protein, peptide, and nucleic acid drug delivery. Accounts Chem. Res. 44:2 (2010), 147–156.
39. Mulet, X., Boyd, B.J., Drummond, C.J., Advances in drug delivery and medical imaging using colloidal lyotropic liquid crystalline dispersions. J. Colloid Interface Sci. 393 (2013), 1–20.
40. Caltagirone, C., Arca, M., Falchi, A.M., Lippolis, V., Meli, V., Monduzzi, M., Nylander, T., Rosa, A., Schmidt, J., Talmon, Y., Solvatochromic fluorescent BODIPY derivative as imaging agent in camptothecin loaded hexosomes for possible theranostic applications. RSC Adv. 5:30 (2015), 23443–23449.
41. Negrini, R., Mezzenga, R., Diffusion, molecular separation, and drug delivery from lipid mesophases with tunable water channels. Langmuir 28:47 (2012), 16455–16462.
42. Kulkarni, C.V., Wachter, W., Iglesias-Salto, G., Engelskirchen, S., Ahualli, S., Monoolein: a magic lipid?. Phys. Chem. Chem. Phys. 13:8 (2011), 3004–3021.
43. Kirby, N.M., Mudie, S.T., Hawley, A.M., Cookson, D.J., Mertens, H.D., Cowieson, N., Samardzic-Boban, V., A low-background-intensity focusing small-angle X-ray scattering undulator beamline. J. Appl. Crystallogr. 46:6 (2013), 1670–1680.
44. Tran, N., Mulet, X., Hawley, A.M., Fong, C., Zhai, J., Le, T.C., Ratcliffe, J., Drummond, C.J., Manipulating the ordered nanostructure of self-assembled monoolein and phytantriol nanoparticles with unsaturated fatty acids. Langmuir, 2018, 10.1021/acs.langmuir.7b03541 (In press).
45. Seddon, J.M., Squires, A.M., Conn, C.E., Ces, O., Heron, A.J., Mulet, X., Shearman, G.C., Templer, R.H., Pressure-jump X-ray studies of liquid crystal transitions in lipids. Philosop. Trans. Royal Soc. A: Mathem. Phys. Eng. Sci. 364:1847 (2006), 2635–2655.
46. Gillis, A., Dupres, V., Delestrait, G., Mahillon, J., Dufrene, Y.F., Nanoscale imaging of Bacillus thuringiensis flagella using atomic force microscopy. Nanoscale 4:5 (2012), 1585–1591.
47. Struck, D.K., Hoekstra, D., Pagano, R.E., Use of resonance energy transfer to monitor membrane fusion. Biochemistry 20:14 (1981), 4093–4099.
48. Tran, N., Hawley, A., Zhai, J., Muir, B.W., Fong, C., Drummond, C.J., Mulet, X., High-throughput screening of saturated fatty acid influence on nanostructure of lyotropic liquid crystalline lipid nanoparticles. Langmuir 32:18 (2016), 4509–4520.
49. Angelov, B., Angelova, A., Drechsler, M., Garamus, V.M., Mutafchieva, R., Lesieur, S., Identification of large channels in cationic PEGylated cubosome nanoparticles by synchrotron radiation SAXS and Cryo-TEM imaging. Soft Matter 11:18 (2015), 3686–3692.
50. Zhai, J., Tran, N., Sarkar, S., Fong, C., Mulet, X., Drummond, C.J., Self-assembled lyotropic liquid crystalline phase behavior of monoolein-capric acid–phospholipid nanoparticulate systems. Langmuir 33:10 (2017), 2571–2580.
51. Barauskas, J., Johnsson, M., Joabsson, F., Tiberg, F., Cubic phase nanoparticles (cubosome): principles for controlling size, structure, and stability. Langmuir 21:6 (2005), 2569–2577.
52. Valldeperas, M., Wiśniewska, M., Ram-On, M., Kesselman, E., Danino, D., Nylander, T., Barauskas, J., Sponge phases and nanoparticle dispersions in aqueous mixtures of mono-and diglycerides. Langmuir 32:34 (2016), 8650–8659.
53. Chen, Y., Angelova, A., Angelov, B., Drechsler, M., Garamus, V.M., Willumeit-Römer, R., Zou, A., Sterically stabilized spongosomes for multidrug delivery of anticancer nanomedicines. J. Mater. Chem. B 3:39 (2015), 7734–7744.
54. Foldes, M., Munro, R., Sorrell, T., Shanker, S., Toohey, M., In-vitro effects of vancomycin, rifampicin, and fusidic acid, alone and in combination, against methicillin-resistant Staphylococcus aureus. J. Antimicrob. Chemother. 11:1 (1983), 21–26.
55. Aubry-Damon, H., Soussy, C.-J., Courvalin, P., Characterization of mutations in therpob gene that confer rifampin resistance inStaphylococcus aureus. Antimicrob. Agents Chemother. 42:10 (1998), 2590–2594.
56. Spicer, P.T., Progress in liquid crystalline dispersions: cubosomes. Curr. Opin. Colloid Interface Sci. 10:5 (2005), 274–279.
57. Eaton, P., Fernandes, J.C., Pereira, E., Pintado, M.E., Xavier Malcata, F., Atomic force microscopy study of the antibacterial effects of chitosans on Escherichia coli and Staphylococcus aureus. Ultramicroscopy 108:10 (2008), 1128–1134.
58. I. Gammoudi, V. Raimbault, H. Tarbague, F. Moroté, C. Grauby-Heywang, A. Othmane, R. Kalfat, D. Moynet, D. Rebière, C. Dejous, T. Cohen-Bouhacina, Enhanced bio-inspired microsensor based on microfluidic/bacteria/love wave hybrid structure for continuous control of heavy metals toxicity in liquid medium, Sensors Actuators B: Chem. 198(Suppl. C) (2014) 278–284.
59. Mularski, A., Wilksch, J.J., Hanssen, E., Strugnell, R.A., Separovic, F., Atomic force microscopy of bacteria reveals the mechanobiology of pore forming peptide action. Biochim. Biophys. Acta (BBA) – Biomembr. 1858:6 (2016), 1091–1098.
60. Gottfredsson, M., Erlendsdóttir, H., Sigfússon, Á., Gudmundsson, S., Characteristics and dynamics of bacterial populations during postantibiotic effect determined by flow cytometry. Antimicrob. Agents Chemother. 42:5 (1998), 1005–1011.
61. Barauskas, J., Cervin, C., Jankunec, M., Špandyreva, M., Ribokaitė, K., Tiberg, F., Johnsson, M., Interactions of lipid-based liquid crystalline nanoparticles with model and cell membranes. Int. J. Pharm. 391:1–2 (2010), 284–291.
62. Beaulac, C., Sachetelli, S., Lagace, J., In-vitro bactericidal efficacy of sub-MIC concentrations of liposome-encapsulated antibiotic against gram-negative and gram-positive bacteria. J. Antimicrob. Chemother. 41:1 (1998), 35–41.
63. Yang, D., Pornpattananangkul, D., Nakatsuji, T., Chan, M., Carson, D., Huang, C.-M., Zhang, L., The antimicrobial activity of liposomal lauric acids against Propionibacterium acnes. Biomaterials 30:30 (2009), 6035–6040.
64. Fröhlich, E., The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles. Int. J. Nanomed., 7, 2012, 5577.
65. Lv, H., Zhang, S., Wang, B., Cui, S., Yan, J., Toxicity of cationic lipids and cationic polymers in gene delivery. J. Control. Release 114:1 (2006), 100–109.
66. Goodman, C.M., McCusker, C.D., Yilmaz, T., Rotello, V.M., Toxicity of gold nanoparticles functionalized with cationic and anionic side chains. Bioconjugate Chem. 15:4 (2004), 897–900.
67. Hinton, T.M., Grusche, F., Acharya, D., Shukla, R., Bansal, V., Waddington, L.J., Monaghan, P., Muir, B.W., Bicontinuous cubic phase nanoparticle lipid chemistry affects toxicity in cultured cells. Toxicol. Res. 3:1 (2014), 11–22.
68. Shen, H.-H., Crowston, J.G., Huber, F., Saubern, S., McLean, K.M., Hartley, P.G., The influence of dipalmitoyl phosphatidylserine on phase behaviour of and cellular response to lyotropic liquid crystalline dispersions. Biomaterials 31:36 (2010), 9473–9481.
69. Falchi, A.M., Rosa, A., Atzeri, A., Incani, A., Lampis, S., Meli, V., Caltagirone, C., Murgia, S., Effects of monoolein-based cubosome formulations on lipid droplets and mitochondria of HeLa cells. Toxicol. Res. 4 (2015), 1025–1036.
70. Murgia, S., Falchi, A.M., Mano, M., Lampis, S., Angius, R., Carnerup, A.M., Schmidt, J., Diaz, G., Giacca, M., Talmon, Y., Nanoparticles from lipid-based liquid crystals: emulsifier influence on morphology and cytotoxicity. J. Phys. Chem. B 114:10 (2010), 3518–3525.
71. Rosa, A., Murgia, S., Putzu, D., Meli, V., Falchi, A.M., Monoolein-based cubosomes affect lipid profile in HeLa cells. Chem. Phys. Lipids 191 (2015), 96–105.
72. Zhai, J., Hinton, T.M., Waddington, L.J., Fong, C., Tran, N., Mulet, X., Drummond, C.J., Muir, B.W., Lipid-PEG conjugates sterically stabilise and reduce the toxicity of phytantriol-based lyotropic liquid crystalline nanoparticles. Langmuir 31:39 (2015), 10871–10880.
73. Zhai, J., Suryadinata, R., Luan, B., Tran, N., Hinton, T., Ratcliffe, J., Hao, X., Drummond, C.J., Amphiphilic brush polymers produced by the RAFT polymerisation method stabilise and reduce the cell cytotoxicity of lipid lyotropic liquid crystalline nanoparticles. Faraday Discuss. 191 (2016), 545–563.
74. Biffi, S., Andolfi, L., Caltagirone, C., Garrovo, C., Falchi, A.M., Lippolis, V., Lorenzon, A., Macor, P., Meli, V., Monduzzi, M., Cubosomes for in vivo fluorescence lifetime imaging. Nanotechnology, 28(5), 2016, 055102.
75. Bye, N., Hutt, O.E., Hinton, T.M., Acharya, D., Waddington, L.J., Moffat, B.A., Wright, D.K., Wang, H., Mulet, X., Muir, B.W., Nitroxide loaded hexosomes provide MRI contrast in vivo. Langmuir 30:29 (2014), 8898–8906.
76. Muir, B.W., Acharya, D.P., Kennedy, D.F., Mulet, X., Evans, R.A., Pereira, S.M., Wark, K.L., Boyd, B.J., Nguyen, T.-H., Hinton, T.M., Metal-free and MRI visible theranostic lyotropic liquid crystal nitroxide-based nanoparticles. Biomaterials 33:9 (2012), 2723–2733.
77. Tran, N., Bye, N., Moffat, B.A., Wright, D.K., Cuddihy, A., Hinton, T.M., Hawley, A.M., Reynolds, N.P., Waddington, L.J., Mulet, X., Dual-modality NIRF-MRI cubosomes and hexosomes: high throughput formulation and in vivo biodistribution. Mater. Sci. Eng. C 71 (2016), 584–593.